IVI links with Inviragen to speed up access to dengue vaccines
This article was originally published in Scrip
Executive Summary
The International Vaccine Institute (IVI) has signed a memorandum of understanding to collaborate with the US firm Inviragen to hasten the development, launch and distribution of an affordable vaccine for dengue.